VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
LFMD
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
LFMDLifeMD, Inc.
$2.19$106M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
LFMD logo

LifeMD, Inc.

LFMD
NASDAQ · Healthcare Software & Telehealth
$2.19
At close - Nov 13, 4:00 PM EST - USD
Market Cap$106M
P/E-4.8x
52W High$5.38
Volume6.14M
OverviewTerminalAnalysisFinancialsValuationEarningsBreakoutsOwnership
VCP Research Verdict2026Q2

Revenue Contraction and Persistent Losses Cloud LifeMD Recovery Case

LifeMD's gross margin widened to 88.8% in 2026Q2, but revenue fell 24.0% year-over-year to $47.3M and SG&A of $41.7M consumed nearly all of the $42.0M gross profit, leaving a $7.1M operating loss.

GrowthContracting
ProfitabilityNegative
ValuationReview
TechnicalsWeak
Explore valuation models
MARKET ACTION

LFMD price & volume

Price trend, volume and key moving averages

Launch Terminal
Loading chart...
Decision Checklist4 Core Signals

What matters now

The signals most likely to change the investment case.

01

Earnings momentum

4/12 Beats

EPS beat 4 of last 12 quarters

02

Valuation risk

-117% Peers

P/E is 117% below peer median

03

Market leadership

RS 18 · Lag

Laggard (Underperforming 82% of market)

04

Weak Trend

Below 200DMA

Price < 200DMA

Next CatalystEstimated earnings · Feb 12

Market performance

Price History →

Trailing total returns as of 11/16/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).

YTD Return
LFMD-37.11%
S&P 500 (^GSPC)+10.42%
1-Year Return
LFMD-52.49%
S&P 500 (^GSPC)+12.25%
3-Year Return
LFMD-69.08%
S&P 500 (^GSPC)+98.82%
5-Year Return
LFMD-50.89%
S&P 500 (^GSPC)+108.53%

Growth & profitability

Annual revenue & EPS trend
Revenue FY25
$194M-8.7% YoY
Net income FY25
-$7M+62.4% YoY
Free cash flow FY25
-$1M-120.7% YoY
Operating margin FY25
-4%+3.6 pts YoY
ROIC (FY25)-
Avg ROIC 5Y-
ROE (TTM)-192.4%
Piotroski Score5 / 9
Financial Statements →
03

Monitor what changed

Recent results and news deserve attention only when they alter the forward view.

OPERATING RESULTS

Recent Earnings

Earnings History
EPS Beat Rate4/12 (33%)
Revenue Beat Rate8/12 (67%)
QuarterEPS (Act vs Est)Revenue (Act vs Est)
Q4 2026Latest
Nov 12, 2026
-$0.11+22.2%
vs -$0.14
$45M-8.6%
vs $49M
Q3 2026
Aug 5, 2026
-$0.16-9.8%
vs -$0.15
$47M-3.8%
vs $49M
Q2 2026
May 6, 2026
-$0.20-42.9%
vs -$0.14
$50M+2.7%
vs $49M
Q2 2026
Mar 9, 2026
-$0.04-300.0%
vs -$0.01
$47M+2.3%
vs $46M
Historical baseline: 12 quarters analyzedGAAP / Adjusted
MARKET COVERAGE

Latest News

4 Stories
Seeking Alpha·3d ago
LifeMD, Inc. (LFMD) Q3 2026 Earnings Call Transcript

LifeMD, Inc. (LFMD) Q3 2026 Earnings Call Transcript

Zacks Investment Research·4d ago
LifeMD, Inc. (LFMD) Reports Q3 Loss, Misses Revenue Estimates

LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.14. This compares to a loss of $0.1 per share a year ago.

MarketBeat·4d ago
What LifeMD (LFMD) Said on Its Q3 Earnings Call

LifeMD NASDAQ: LFMD lowered its full-year revenue and adjusted EBITDA outlook after third-quarter sales fell short of its forecast, as the virtual healthcare company cut marketing spending and took longer than expected to launch branded GLP-1 fulfillment arrangements.

GlobeNewsWire·4d ago
LifeMD Reports Third Quarter 2026 Results

Third quarter 2026 revenue of $44.6 million; adjusted EBITDA loss of approximately $0.4 million, within the Company's guidance range of negative $1 million to positive $2 million. Adjusted EBITDA improved approximately $3.1 million sequentially from an adjusted EBITDA loss of $3.5 million in the second quarter of 2026, driven primarily by a 34% sequential reduction in selling and marketing expenses and reduction of overall non-clinical expenses.

Filtered for LifeMD, Inc.More Headlines
04

Compare before deciding

Benchmark LFMD against direct peers instead of judging its metrics in isolation.

Peers Comparison

Key metrics vs top competitors for LifeMD, Inc. (LFMD)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
LFMD logoLFMDLifeMD, Inc.Current
$2.19$105.91M-4.81-8.66%-11.6%-192.39%3.14%
HIMS logoHIMSHims & Hers Health, Inc.
$19.73$4.4B-24.1759%-6.65%-45.81%—
NUVB logoNUVBNuvation Bio Inc.
$3.99$1.39B-10.33698.96%-67.38%-49.11%—
DOCS logoDOCSDoximity, Inc.
$33.34$6.24B44.8113.05%21.12%14.81%—
OPRX logoOPRXOptimizeRx Corp.
$7.34$137.74M28.1218.78%5.33%3.84%—
TDOC logoTDOCTeladoc Health, Inc.
$8.80$1.59B-10.34-1.54%-6.27%-11.63%—

Compare LFMD vs Peers

LifeMD, Inc. (LFMD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HIMS

Most directly comparable listed peer for LFMD.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare LFMD against a more recognizable public peer.

Peer Set

Compare Top 5

vs HIMS, NUVB, DOCS, OPRX

05

Keep researching

Verify the primary filings, follow material updates, and answer the remaining questions.

LFMD SEC Filings & Documents

LifeMD, Inc. (LFMD) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Aug 5, 2026·SEC

Material company update

Jun 22, 2026·SEC

Material company update

May 6, 2026·SEC

10-K Annual Reports

4
FY 2026

Mar 10, 2026·SEC

FY 2025

Mar 11, 2025·SEC

FY 2024

Mar 11, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

Aug 5, 2026·SEC

FY 2026

May 6, 2026·SEC

FY 2025

Nov 17, 2025·SEC

Get notified when LFMD posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

LFMD Frequently Asked Questions

LifeMD, Inc. (LFMD) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is LifeMD, Inc.'s revenue?

LifeMD, Inc. (LFMD) reported $188.9M in revenue over the trailing twelve months. Revenue was $194.1M in fiscal year 2025. That is 25989% more than the $0.7M of fiscal year 2011.

How fast is LifeMD, Inc. growing?

LifeMD, Inc. (LFMD) revenue fell by 25.1% over the trailing twelve months, compared with the twelve months before.

Is LFMD profitable?

No. LifeMD, Inc. (LFMD) reported a net loss of $21.9M over the trailing twelve months.

Dividend & Returns
Does LFMD pay dividends?

Yes. LifeMD, Inc. (LFMD) pays a dividend that yields 3.14% at the current price, a moderate yield.

What is LFMD's return on equity?

LifeMD, Inc. (LFMD) had a return on equity (ROE) of -192.4% over the trailing twelve months. A negative ROE means the company lost money over the period.

What is LifeMD, Inc.'s free cash flow?

LifeMD, Inc. (LFMD) had negative free cash flow of $16.1M over the trailing twelve months.

What if you invested $1,000 in LFMD back in 2011?

Total return calculator · dividends reinvested · 15+ years of data

See returns →